Predicting the Risk of Adverse Neonatal Outcomes in Women With Insulin-Treated Diabetes: Is It Time for a Pregnancy-Specific Glycemic Risk Index (GRI)?
Pregnant women with insulin-treated diabetes reporting adverse neonatal outcomes spent more time in hyperglycemia, particularly in extreme hyperglycemia. Therefore, the level of hyperglycemia should always be assessed during pregnancy. The pGRI, emphasizing extreme hyperglycemia, may be a novel comprehensive tool for assessing the risk of adverse neonatal outcomes.
Authors
- Piero Marchetti (ORCID: https://orcid.org/0000-0003-4907-0635)
- Michele Aragona (ORCID: https://orcid.org/0000-0002-5982-7913)
- Fabrizia Citro (ORCID: https://orcid.org/0009-0000-1673-2327)
- Cristina Bianchi (ORCID: https://orcid.org/0000-0003-2799-2380)
- Lorella Battini (ORCID: https://orcid.org/0000-0003-3805-7013)
- Tommaso Belcari
- Alessandra Bertolotto
- Caterina Venturi
- Federico Galleano
Institutions
- University of Pisa (IT)
- Azienda Ospedaliera Universitaria Pisana (IT)
Publication Details
- Journal
- Journal of Diabetes Science and Technology
- Published
- 2024-10-17
- DOI
- https://doi.org/10.1177/19322968241289957
- Citations
- 1
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.36
Funders
- European Commission